glp-1 obesity drug study august 2025 trends 2025: real-world data, patient outcomes & future therapies GLP-1s in 2025: Who's Using

The success of tirzepatide has validated the multi-agonist approach, driving substantial research and development in this area

Instead of relying on traditional doctor visits, insurance battles, or drawn-out lab approvals, FuturHealth uses a telehealth-first model that puts speed, affordability, and patient autonomy at the center of care

For youths considering GLP-1s, the decision should be at the discretion of the physician, the adolescent patient and their caregiver, Ms

These findings are the first to establish a functional role for GLP-1-producing NTSVTA projections in cocaine seeking and support the hypothesis that endogenous GLP-1R-expressing circuits are important anti-craving pathways that when activated reduce drug seeking during abstinence

In diabetes-related AD, GLP-1 promotes mitochondrial biogenesis and the antioxidant system by regulating the PGC-1a signaling pathway in vivo to directly reverse tau hyperphosphorylation